BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 29970503)

  • 21. Annexin A7 gene is an important factor in the lymphatic metastasis of tumors.
    Jin YL; Wang ZQ; Qu H; Wang HX; Ibrahim MM; Zhang J; Huang YH; Wu J; Bai LL; Wang XY; Meng JY; Tang JW
    Biomed Pharmacother; 2013 May; 67(4):251-9. PubMed ID: 23540285
    [TBL] [Abstract][Full Text] [Related]  

  • 22. TCF7 is suppressed by the androgen receptor via microRNA-1-mediated downregulation and is involved in the development of resistance to androgen deprivation in prostate cancer.
    Siu MK; Chen WY; Tsai HY; Chen HY; Yin JJ; Chen CL; Tsai YC; Liu YN
    Prostate Cancer Prostatic Dis; 2017 Jun; 20(2):172-178. PubMed ID: 28220803
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of a small molecule targeting annexin A7.
    Li H; Liu N; Wang S; Wang L; Zhao J; Su L; Zhang Y; Zhang S; Xu Z; Zhao B; Miao J
    Biochim Biophys Acta; 2013 Sep; 1833(9):2092-9. PubMed ID: 23651924
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Eucalyptol suppresses matrix metalloproteinase-9 expression through an extracellular signal-regulated kinase-dependent nuclear factor-kappa B pathway to exert anti-inflammatory effects in an acute lung inflammation model.
    Kim KY; Lee HS; Seol GH
    J Pharm Pharmacol; 2015 Aug; 67(8):1066-74. PubMed ID: 25773735
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Androgen-induced miR-135a acts as a tumor suppressor through downregulating RBAK and MMP11, and mediates resistance to androgen deprivation therapy.
    Wan X; Pu H; Huang W; Yang S; Zhang Y; Kong Z; Yang Z; Zhao P; Li A; Li T; Li Y
    Oncotarget; 2016 Aug; 7(32):51284-51300. PubMed ID: 27323416
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synergistic antitumor effect of NVP-BEZ235 and sunitinib on docetaxel-resistant human castration-resistant prostate cancer cells.
    Park HS; Hong SK; Oh MM; Yoon CY; Jeong SJ; Byun SS; Cheon J; Lee SE; Moon du G
    Anticancer Res; 2014 Jul; 34(7):3457-68. PubMed ID: 24982354
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Targeting Cancer Stem Cells in Castration-Resistant Prostate Cancer.
    Yun EJ; Zhou J; Lin CJ; Hernandez E; Fazli L; Gleave M; Hsieh JT
    Clin Cancer Res; 2016 Feb; 22(3):670-9. PubMed ID: 26490309
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MicroRNA-181a promotes docetaxel resistance in prostate cancer cells.
    Armstrong CM; Liu C; Lou W; Lombard AP; Evans CP; Gao AC
    Prostate; 2017 Jun; 77(9):1020-1028. PubMed ID: 28485104
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comprehensive Profiling of the Androgen Receptor in Liquid Biopsies from Castration-resistant Prostate Cancer Reveals Novel Intra-AR Structural Variation and Splice Variant Expression Patterns.
    De Laere B; van Dam PJ; Whitington T; Mayrhofer M; Diaz EH; Van den Eynden G; Vandebroek J; Del-Favero J; Van Laere S; Dirix L; Grönberg H; Lindberg J
    Eur Urol; 2017 Aug; 72(2):192-200. PubMed ID: 28104311
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A Constitutive Intrinsic Inflammatory Signaling Circuit Composed of miR-196b, Meis2, PPP3CC, and p65 Drives Prostate Cancer Castration Resistance.
    Jeong JH; Park SJ; Dickinson SI; Luo JL
    Mol Cell; 2017 Jan; 65(1):154-167. PubMed ID: 28041912
    [TBL] [Abstract][Full Text] [Related]  

  • 31. EGFR mediates docetaxel resistance in human castration-resistant prostate cancer through the Akt-dependent expression of ABCB1 (MDR1).
    Hour TC; Chung SD; Kang WY; Lin YC; Chuang SJ; Huang AM; Wu WJ; Huang SP; Huang CY; Pu YS
    Arch Toxicol; 2015 Apr; 89(4):591-605. PubMed ID: 24888374
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antitumor effects of carnertinib in castration resistant prostate cancer models: a comparative study with erlotinib.
    Gravina GL; Marampon F; Piccolella M; Biordi L; Ficorella C; Motta M; Jannini EA; Tombolini V; Festuccia C
    Prostate; 2011 Oct; 71(14):1481-91. PubMed ID: 21446006
    [TBL] [Abstract][Full Text] [Related]  

  • 33. ACSL4 promotes prostate cancer growth, invasion and hormonal resistance.
    Wu X; Deng F; Li Y; Daniels G; Du X; Ren Q; Wang J; Wang LH; Yang Y; Zhang V; Zhang D; Ye F; Melamed J; Monaco ME; Lee P
    Oncotarget; 2015 Dec; 6(42):44849-63. PubMed ID: 26636648
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Protective effect of linalool, myrcene and eucalyptol against t-butyl hydroperoxide induced genotoxicity in bacteria and cultured human cells.
    Mitić-Culafić D; Zegura B; Nikolić B; Vuković-Gacić B; Knezević-Vukcević J; Filipic M
    Food Chem Toxicol; 2009 Jan; 47(1):260-6. PubMed ID: 19049815
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mechanisms of Therapeutic Resistance in Prostate Cancer.
    Nakazawa M; Paller C; Kyprianou N
    Curr Oncol Rep; 2017 Feb; 19(2):13. PubMed ID: 28229393
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Repurposing of phentolamine as a potential anticancer agent against human castration-resistant prostate cancer: A central role on microtubule stabilization and mitochondrial apoptosis pathway.
    Ho CH; Hsu JL; Liu SP; Hsu LC; Chang WL; Chao CC; Guh JH
    Prostate; 2015 Sep; 75(13):1454-66. PubMed ID: 26180030
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Numb
    Guo Y; Zhang K; Cheng C; Ji Z; Wang X; Wang M; Chu M; Tang DG; Zhu HH; Gao WQ
    Clin Cancer Res; 2017 Nov; 23(21):6744-6756. PubMed ID: 28751447
    [No Abstract]   [Full Text] [Related]  

  • 38. Poloxamer P85 increases anticancer activity of Schiff base against prostate cancer in vitro and in vivo.
    Demirci S; Doğan A; Başak Türkmen N; Telci D; Çağlayan AB; Beker MÇ; Kiliç E; Özkan F; Dede B; Şahin F
    Anticancer Drugs; 2017 Sep; 28(8):869-879. PubMed ID: 28614092
    [TBL] [Abstract][Full Text] [Related]  

  • 39. TIA1 interacts with annexin A7 in regulating vascular endothelial cell autophagy.
    Huang S; Liu N; Li H; Zhao J; Su L; Zhang Y; Zhang S; Zhao B; Miao J
    Int J Biochem Cell Biol; 2014 Dec; 57():115-22. PubMed ID: 25461769
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High expression of TROP2 characterizes different cell subpopulations in androgen-sensitive and androgen-independent prostate cancer cells.
    Xie J; Mølck C; Paquet-Fifield S; Butler L; ; Sloan E; Ventura S; Hollande F
    Oncotarget; 2016 Jul; 7(28):44492-44504. PubMed ID: 27283984
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.